Prescription and OTC drugs' effects on safe vehicle operation being considered<br>for new label requirements

The possibility of new label requirements for certain prescription and non- prescription medicines was discussed at mid-Nov. meeting between the FDA and the National Transportation Safety Board. The NTSB has recorded thousands of vehicle accidents, resulting in 100 deaths, all linked to the driver’s use of such medications as antihistamines, muscle relaxants, painkillers, anti-anxiety drugs and anti-depressants. The FDA may announce policy actions within one year. NCPIE has always urged consumers to ask their health care professionals, “What activities should I avoid while taking this medicine?”
http://www.ama-assn.org/sci-pubs/amnews/pick_01/hlsb1203.htm